Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Jan;64(1):310–318. doi: 10.1128/iai.64.1.310-318.1996

Staphylococcus aureus binding to human nasal mucin.

J Shuter 1, V B Hatcher 1, F D Lowy 1
PMCID: PMC173761  PMID: 8557357

Abstract

Colonization of human nasal mucosa with Staphylococcus aureus sets the stage for subsequent systemic infection. This study characterizes S. aureus adhesion to nasal mucosa in vitro and investigates the interaction of S. aureus with human nasal mucin. S. aureus binding to cell-associated and cell-free mucus was greater than to nonmucin-coated epithelial cells. Scanning electron microscopy of S. aureus incubated with human nasal mucosal tissue showed minimal binding to ciliated respiratory epithelium. In a solid-phase assay, S. aureus bound to purified human nasal mucin-coated wells significantly more than to bovine serum albumin-coated microtiter wells. Binding to mucin was saturable in a dose- and time-dependent fashion. Staphylococcal adherence to human nasal mucin was inhibited by bovine submaxillary mucin but not by fibrinogen. Pretreatment of mucin with periodate but not with pronase reduced adherence. Trypsin treatment of the bacteria significantly reduced adherence to mucin. 125I-labelled nasal mucin bound to two surface proteins (138 and 127 kDa) of lysostaphin-solubilized S. aureus. Binding to human nasal mucin occurs in part via specific adhesin-receptor interactions involving bacterial proteins and the carbohydrate moiety in mucin. These experiments suggest that S. aureus binding to mucin may be critical for colonization of the nasopharyngeal mucosa.

Full Text

The Full Text of this article is available as a PDF (873.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ali M. Y. Histology of the human nasopharyngeal mucosa. J Anat. 1965 Jul;99(Pt 3):657–672. [PMC free article] [PubMed] [Google Scholar]
  2. Aly R., Maibach H. I., Shinefield H. R., Mandel A., Strauss W. G. Bacterial interference among strains of Staphylococcus aureus in man. J Infect Dis. 1974 Jun;129(6):720–724. doi: 10.1093/infdis/129.6.720. [DOI] [PubMed] [Google Scholar]
  3. Aly R., Shinefield H. I., Strauss W. G., Maibach H. I. Bacterial adherence to nasal mucosal cells. Infect Immun. 1977 Sep;17(3):546–549. doi: 10.1128/iai.17.3.546-549.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Aly R., Shinefield H. R., Litz C., Maibach H. I. Role of teichoic acid in the binding of Staphylococcus aureus to nasal epithelial cells. J Infect Dis. 1980 Apr;141(4):463–465. doi: 10.1093/infdis/141.4.463. [DOI] [PubMed] [Google Scholar]
  5. Bessen D., Fischetti V. A. Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A. J Exp Med. 1988 Jun 1;167(6):1945–1950. doi: 10.1084/jem.167.6.1945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bibel D. J., Aly R., Shinefield H. R., Maibach H. I., Strauss W. G. Importance of the keratinized epithelial cell in bacterial adherence. J Invest Dermatol. 1982 Oct;79(4):250–253. doi: 10.1111/1523-1747.ep12500072. [DOI] [PubMed] [Google Scholar]
  7. Biesbrock A. R., Reddy M. S., Levine M. J. Interaction of a salivary mucin-secretory immunoglobulin A complex with mucosal pathogens. Infect Immun. 1991 Oct;59(10):3492–3497. doi: 10.1128/iai.59.10.3492-3497.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Carlstedt I., Lindgren H., Sheehan J. K., Ulmsten U., Wingerup L. Isolation and characterization of human cervical-mucus glycoproteins. Biochem J. 1983 Apr 1;211(1):13–22. doi: 10.1042/bj2110013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Doebbeling B. N., Breneman D. L., Neu H. C., Aly R., Yangco B. G., Holley H. P., Jr, Marsh R. J., Pfaller M. A., McGowan J. E., Jr, Scully B. E. Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group. Clin Infect Dis. 1993 Sep;17(3):466–474. doi: 10.1093/clinids/17.3.466. [DOI] [PubMed] [Google Scholar]
  10. Drutz D. J., Van Way M. H., Schaffner W., Koenig M. G. Bacterial interference in the therapy of recurrent staphylococcal infections. Multiple abscesses due to the implantation of the 502A strain of staphylococcus. N Engl J Med. 1966 Nov 24;275(21):1161–1165. doi: 10.1056/NEJM196611242752104. [DOI] [PubMed] [Google Scholar]
  11. Holden K. G., Yim N. C., Griggs L. J., Weisbach J. A. Gel electrophoresis of mucous glycoproteins. I. Effect of gel porosity. Biochemistry. 1971 Aug 3;10(16):3105–3109. doi: 10.1021/bi00792a019. [DOI] [PubMed] [Google Scholar]
  12. Kreiswirth B. N., Löfdahl S., Betley M. J., O'Reilly M., Schlievert P. M., Bergdoll M. S., Novick R. P. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature. 1983 Oct 20;305(5936):709–712. doi: 10.1038/305709a0. [DOI] [PubMed] [Google Scholar]
  13. Krivan H. C., Roberts D. D., Ginsburg V. Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids. Proc Natl Acad Sci U S A. 1988 Aug;85(16):6157–6161. doi: 10.1073/pnas.85.16.6157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kronvall G., Dossett J. H., Quie P. G., Williams R. C. Occurrence of protein a in staphylococcal strains: quantitative aspects and correlation to antigenic and bacteriophage types. Infect Immun. 1971 Jan;3(1):10–15. doi: 10.1128/iai.3.1.10-15.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  16. Layton M. C., Patterson J. E. Mupirocin resistance among consecutive isolates of oxacillin-resistant and borderline oxacillin-resistant Staphylococcus aureus at a university hospital. Antimicrob Agents Chemother. 1994 Jul;38(7):1664–1667. doi: 10.1128/aac.38.7.1664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lee D. S., Griffiths B. W. Comparative studies of Iodo-bead and chloramine-T methods for the radioiodination of human alpha-fetoprotein. J Immunol Methods. 1984 Nov 16;74(1):181–189. doi: 10.1016/0022-1759(84)90379-x. [DOI] [PubMed] [Google Scholar]
  18. Lowy F. D., Fant J., Higgins L. L., Ogawa S. K., Hatcher V. B. Staphylococcus aureus--human endothelial cell interactions. J Ultrastruct Mol Struct Res. 1988 Feb;98(2):137–146. doi: 10.1016/s0889-1605(88)80906-6. [DOI] [PubMed] [Google Scholar]
  19. Lowy F. D., Walsh J. A., Mayers M. M., Klein R. S., Steigbigel N. H. Antibiotic activity in vitro against methicillin-resistant Staphylococcus epidermidis and therapy of an experimental infection. Antimicrob Agents Chemother. 1979 Sep;16(3):314–321. doi: 10.1128/aac.16.3.314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Luzar M. A., Coles G. A., Faller B., Slingeneyer A., Dah G. D., Briat C., Wone C., Knefati Y., Kessler M., Peluso F. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med. 1990 Feb 22;322(8):505–509. doi: 10.1056/NEJM199002223220804. [DOI] [PubMed] [Google Scholar]
  21. Mantle M., Forstner G. G., Forstner J. F. Biochemical characterization of the component parts of intestinal mucin from patients with cystic fibrosis. Biochem J. 1984 Dec 1;224(2):345–354. doi: 10.1042/bj2240345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. McAnally T. P., Lewis M. R., Brown D. R. Effect of rifampin and bacitracin on nasal carriers of Staphylococcus aureus. Antimicrob Agents Chemother. 1984 Apr;25(4):422–426. doi: 10.1128/aac.25.4.422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Murakami K., Tomasz A. Involvement of multiple genetic determinants in high-level methicillin resistance in Staphylococcus aureus. J Bacteriol. 1989 Feb;171(2):874–879. doi: 10.1128/jb.171.2.874-879.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Murray B. E. Can antibiotic resistance be controlled? N Engl J Med. 1994 Apr 28;330(17):1229–1230. doi: 10.1056/NEJM199404283301710. [DOI] [PubMed] [Google Scholar]
  25. Mylotte J. M., McDermott C., Spooner J. A. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis. 1987 Sep-Oct;9(5):891–907. doi: 10.1093/clinids/9.5.891. [DOI] [PubMed] [Google Scholar]
  26. Nesbitt W. E., Doyle R. J., Taylor K. G. Hydrophobic interactions and the adherence of Streptococcus sanguis to hydroxylapatite. Infect Immun. 1982 Nov;38(2):637–644. doi: 10.1128/iai.38.2.637-644.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Neu H. C. The crisis in antibiotic resistance. Science. 1992 Aug 21;257(5073):1064–1073. doi: 10.1126/science.257.5073.1064. [DOI] [PubMed] [Google Scholar]
  28. Noble W. C., Valkenburg H. A., Wolters C. H. Carriage of Staphylococcus aureus in random samples of a normal population. J Hyg (Lond) 1967 Dec;65(4):567–573. doi: 10.1017/s002217240004609x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Noble W. C., Virani Z., Cree R. G. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett. 1992 Jun 1;72(2):195–198. doi: 10.1016/0378-1097(92)90528-v. [DOI] [PubMed] [Google Scholar]
  30. Ogawa S. K., Yurberg E. R., Hatcher V. B., Levitt M. A., Lowy F. D. Bacterial adherence to human endothelial cells in vitro. Infect Immun. 1985 Oct;50(1):218–224. doi: 10.1128/iai.50.1.218-224.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Oshida T., Tomasz A. Isolation and characterization of a Tn551-autolysis mutant of Staphylococcus aureus. J Bacteriol. 1992 Aug;174(15):4952–4959. doi: 10.1128/jb.174.15.4952-4959.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Patel A. H., Nowlan P., Weavers E. D., Foster T. Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect Immun. 1987 Dec;55(12):3103–3110. doi: 10.1128/iai.55.12.3103-3110.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. ROE J. H. The determination of sugar in blood and spinal fluid with anthrone reagent. J Biol Chem. 1955 Jan;212(1):335–343. [PubMed] [Google Scholar]
  34. Ramisse F., Szatanik M., Binder P., Alonso J. M. Passive local immunotherapy of experimental staphylococcal pneumonia with human intravenous immunoglobulin. J Infect Dis. 1993 Oct;168(4):1030–1033. doi: 10.1093/infdis/168.4.1030. [DOI] [PubMed] [Google Scholar]
  35. Ramphal R. The role of bacterial adhesion in cystic fibrosis including the staphylococcal aspect. Infection. 1990 Jan-Feb;18(1):61–64. doi: 10.1007/BF01644188. [DOI] [PubMed] [Google Scholar]
  36. Sajjan U. S., Corey M., Karmali M. A., Forstner J. F. Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest. 1992 Feb;89(2):648–656. doi: 10.1172/JCI115631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sajjan U., Reisman J., Doig P., Irvin R. T., Forstner G., Forstner J. Binding of nonmucoid Pseudomonas aeruginosa to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest. 1992 Feb;89(2):657–665. doi: 10.1172/JCI115632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Sanford B. A., Thomas V. L., Ramsay M. A. Binding of staphylococci to mucus in vivo and in vitro. Infect Immun. 1989 Dec;57(12):3735–3742. doi: 10.1128/iai.57.12.3735-3742.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Schaberg D. R., Culver D. H., Gaynes R. P. Major trends in the microbial etiology of nosocomial infection. Am J Med. 1991 Sep 16;91(3B):72S–75S. doi: 10.1016/0002-9343(91)90346-y. [DOI] [PubMed] [Google Scholar]
  40. Schwab U. E., Wold A. E., Carson J. L., Leigh M. W., Cheng P. W., Gilligan P. H., Boat T. F. Increased adherence of Staphylococcus aureus from cystic fibrosis lungs to airway epithelial cells. Am Rev Respir Dis. 1993 Aug;148(2):365–369. doi: 10.1164/ajrccm/148.2.365. [DOI] [PubMed] [Google Scholar]
  41. Sheagren J. N. Staphylococcus aureus. The persistent pathogen (second of two parts). N Engl J Med. 1984 May 31;310(22):1437–1442. doi: 10.1056/NEJM198405313102206. [DOI] [PubMed] [Google Scholar]
  42. Switalski L. M., Patti J. M., Butcher W., Gristina A. G., Speziale P., Hök M. A collagen receptor on Staphylococcus aureus strains isolated from patients with septic arthritis mediates adhesion to cartilage. Mol Microbiol. 1993 Jan;7(1):99–107. doi: 10.1111/j.1365-2958.1993.tb01101.x. [DOI] [PubMed] [Google Scholar]
  43. Thomas V. L., Sanford B. A., Ramsay M. A. Calcium- and mucin-binding proteins of staphylococci. J Gen Microbiol. 1993 Mar;139(3):623–629. doi: 10.1099/00221287-139-3-623. [DOI] [PubMed] [Google Scholar]
  44. Tomasz A. Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop. N Engl J Med. 1994 Apr 28;330(17):1247–1251. doi: 10.1056/NEJM199404283301725. [DOI] [PubMed] [Google Scholar]
  45. Tompkins D. C., Blackwell L. J., Hatcher V. B., Elliott D. A., O'Hagan-Sotsky C., Lowy F. D. Staphylococcus aureus proteins that bind to human endothelial cells. Infect Immun. 1992 Mar;60(3):965–969. doi: 10.1128/iai.60.3.965-969.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Tompkins D. C., Hatcher V. B., Patel D., Orr G. A., Higgins L. L., Lowy F. D. A human endothelial cell membrane protein that binds Staphylococcus aureus in vitro. J Clin Invest. 1990 Apr;85(4):1248–1254. doi: 10.1172/JCI114560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Tuazon C. U., Perez A., Kishaba T., Sheagren J. N. Staphylococcus aureus among insulin-injecting diabetic patients. An increased carrier rate. JAMA. 1975 Mar 24;231(12):1272–1272. [PubMed] [Google Scholar]
  49. Tuazon C. U., Sheagren J. N. Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J Infect Dis. 1974 Jun;129(6):725–727. doi: 10.1093/infdis/129.6.725. [DOI] [PubMed] [Google Scholar]
  50. Tuazon C. U., Sheagren J. N. Staphlococcal endocarditis in parenteral drug abusers: source of the organism. Ann Intern Med. 1975 Jun;82(6):788–790. doi: 10.7326/0003-4819-82-6-788. [DOI] [PubMed] [Google Scholar]
  51. Vishwanath S., Ramphal R. Adherence of Pseudomonas aeruginosa to human tracheobronchial mucin. Infect Immun. 1984 Jul;45(1):197–202. doi: 10.1128/iai.45.1.197-202.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. WILLIAMS R. E. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev. 1963 Mar;27:56–71. doi: 10.1128/br.27.1.56-71.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Weinke T., Schiller R., Fehrenbach F. J., Pohle H. D. Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis. 1992 Nov;11(11):985–989. doi: 10.1007/BF01967787. [DOI] [PubMed] [Google Scholar]
  54. Yu V. L., Goetz A., Wagener M., Smith P. B., Rihs J. D., Hanchett J., Zuravleff J. J. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med. 1986 Jul 10;315(2):91–96. doi: 10.1056/NEJM198607103150204. [DOI] [PubMed] [Google Scholar]
  55. de Lencastre H., Couto I., Santos I., Melo-Cristino J., Torres-Pereira A., Tomasz A. Methicillin-resistant Staphylococcus aureus disease in a Portuguese hospital: characterization of clonal types by a combination of DNA typing methods. Eur J Clin Microbiol Infect Dis. 1994 Jan;13(1):64–73. doi: 10.1007/BF02026129. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES